Mather Group, Llc. Atri Cure, Inc. Transaction History
Mather Group, Llc.
- $7.74 Billion
- Q3 2024
A detailed history of Mather Group, Llc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 70 shares of ATRC stock, worth $2,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 730
90.41%
Holding current value
$2,060
Previous $16,000
93.75%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ATRC
# of Institutions
206Shares Held
49.3MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$136 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$136 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$124 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$78.7 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$58.8 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.37B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...